A Phase 3 study for the treatment of CMV who have received a HSCT or SOT
A Phase 3, open-label, single-arm, repeated-dose
study to evaluate the safety and tolerability,
pharmacokinetics, and antiviral activity of
maribavir for the treatment of cytomegalovirus
(CMV) infection in children and adolescents who
have received a hematopoietic stem cell
transplant (HSCT) or a solid organ transplant
(SOT)
Today’s rapidly changing healthcare landscape presents new challenges and disruptions to patient...
A Phase 3b/4, Randomized Study in Adults w/Obesity or Overweight w/Weight-Related Comorbidities...
This app is specifically intended for study participants in the Frontier4 (NN7769-4532)...
This app is specifically intended for study participants in the Bristol Myers...
You are invited to participate in the Bristol Myers Squibb CA116-001 study....
You are invited to participate in the Versanis VER201-PH2-031 study...
Created with AppPage.net
Similar Apps - visible in preview.